These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 21734404)

  • 1. Genome-wide linkage analysis to identify genetic modifiers of ALK mutation penetrance in familial neuroblastoma.
    Devoto M; Specchia C; Laudenslager M; Longo L; Hakonarson H; Maris J; Mossé Y
    Hum Hered; 2011; 71(2):135-9. PubMed ID: 21734404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of ALK as a major familial neuroblastoma predisposition gene.
    Mossé YP; Laudenslager M; Longo L; Cole KA; Wood A; Attiyeh EF; Laquaglia MJ; Sennett R; Lynch JE; Perri P; Laureys G; Speleman F; Kim C; Hou C; Hakonarson H; Torkamani A; Schork NJ; Brodeur GM; Tonini GP; Rappaport E; Devoto M; Maris JM
    Nature; 2008 Oct; 455(7215):930-5. PubMed ID: 18724359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic linkage analysis of a large family identifies
    Puigdevall P; Piccari L; Blanco I; Barberà JA; Geiger D; Badenas C; Milà M; Castelo R; Madrigal I
    J Med Genet; 2019 Jul; 56(7):481-490. PubMed ID: 30894412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Copy number status and mutation analyses of anaplastic lymphoma kinase (ALK) gene in 90 sporadic neuroblastoma tumors.
    Bagci O; Tumer S; Olgun N; Altungoz O
    Cancer Lett; 2012 Apr; 317(1):72-7. PubMed ID: 22085494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic predisposition to familial neuroblastoma: identification of two novel genomic regions at 2p and 12p.
    Longo L; Panza E; Schena F; Seri M; Devoto M; Romeo G; Bini C; Pappalardo G; Tonini GP; Perri P
    Hum Hered; 2007; 63(3-4):205-11. PubMed ID: 17317969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide search for breast cancer linkage in large Icelandic non-BRCA1/2 families.
    Arason A; Gunnarsson H; Johannesdottir G; Jonasson K; Bendahl PO; Gillanders EM; Agnarsson BA; Jönsson G; Pylkäs K; Mustonen A; Heikkinen T; Aittomäki K; Blomqvist C; Melin B; Johannsson OT; Møller P; Winqvist R; Nevanlinna H; Borg A; Barkardottir RB
    Breast Cancer Res; 2010; 12(4):R50. PubMed ID: 20637093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [ALK gene mutations in childhood neuroblastoma].
    Yang CL; Yue LJ; Jiang XP; Wen FQ; Zheng MM
    Zhongguo Dang Dai Er Ke Za Zhi; 2012 Oct; 14(10):763-6. PubMed ID: 23092569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic susceptibility to neuroblastoma.
    Tolbert VP; Coggins GE; Maris JM
    Curr Opin Genet Dev; 2017 Feb; 42():81-90. PubMed ID: 28458126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Abnormality of anaplastic lymphoma kinase gene and its expression in pediatric neuroblastoma].
    Chen S; Zhou C; Ma X; Gong L
    Zhonghua Bing Li Xue Za Zhi; 2014 Aug; 43(8):541-5. PubMed ID: 25346125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of GALNT14 as a novel neuroblastoma predisposition gene.
    De Mariano M; Gallesio R; Chierici M; Furlanello C; Conte M; Garaventa A; Croce M; Ferrini S; Tonini GP; Longo L
    Oncotarget; 2015 Sep; 6(28):26335-46. PubMed ID: 26309160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The second-generation ALK inhibitor alectinib effectively induces apoptosis in human neuroblastoma cells and inhibits tumor growth in a TH-MYCN transgenic neuroblastoma mouse model.
    Lu J; Guan S; Zhao Y; Yu Y; Woodfield SE; Zhang H; Yang KL; Bieerkehazhi S; Qi L; Li X; Gu J; Xu X; Jin J; Muscal JA; Yang T; Xu GT; Yang J
    Cancer Lett; 2017 Aug; 400():61-68. PubMed ID: 28455243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High incidence of DNA mutations and gene amplifications of the ALK gene in advanced sporadic neuroblastoma tumours.
    Carén H; Abel F; Kogner P; Martinsson T
    Biochem J; 2008 Dec; 416(2):153-9. PubMed ID: 18990089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncogenic mutations of ALK kinase in neuroblastoma.
    Chen Y; Takita J; Choi YL; Kato M; Ohira M; Sanada M; Wang L; Soda M; Kikuchi A; Igarashi T; Nakagawara A; Hayashi Y; Mano H; Ogawa S
    Nature; 2008 Oct; 455(7215):971-4. PubMed ID: 18923524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomewide linkage analysis in Costa Rican families implicates chromosome 15q14 as a candidate region for OCD.
    Ross J; Badner J; Garrido H; Sheppard B; Chavira DA; Grados M; Woo JM; Doo P; Umaña P; Fournier E; Murray SS; Mathews CA
    Hum Genet; 2011 Dec; 130(6):795-805. PubMed ID: 21691774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intragenic anaplastic lymphoma kinase (ALK) rearrangements: translocations as a novel mechanism of ALK activation in neuroblastoma tumors.
    Fransson S; Hansson M; Ruuth K; Djos A; Berbegall A; Javanmardi N; Abrahamsson J; Palmer RH; Noguera R; Hallberg B; Kogner P; Martinsson T
    Genes Chromosomes Cancer; 2015 Feb; 54(2):99-109. PubMed ID: 25251827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromosome 2p14 is linked to susceptibility to leprosy.
    Yang Q; Liu H; Low HQ; Wang H; Yu Y; Fu X; Yu G; Chen M; Yan X; Chen S; Huang W; Liu J; Zhang F
    PLoS One; 2012; 7(1):e29747. PubMed ID: 22238647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncogenic anaplastic lymphoma kinase (ALK) mutation in neuroblastomas and other pediatric tumors.
    Kwon MJ; Choi YL; Sung KW; Kang SY; Park SM; Choi SY; Kim JS; Suh YL
    Pathol Res Pract; 2011 Oct; 207(10):634-9. PubMed ID: 21940108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome-wide linkage meta-analysis identifies susceptibility loci at 2q34 and 13q31.3 for genetic generalized epilepsies.
    ; Leu C; de Kovel CG; Zara F; Striano P; Pezzella M; Robbiano A; Bianchi A; Bisulli F; Coppola A; Giallonardo AT; Beccaria F; Trenité DK; Lindhout D; Gaus V; Schmitz B; Janz D; Weber YG; Becker F; Lerche H; Kleefuss-Lie AA; Hallman K; Kunz WS; Elger CE; Muhle H; Stephani U; Møller RS; Hjalgrim H; Mullen S; Scheffer IE; Berkovic SF; Everett KV; Gardiner MR; Marini C; Guerrini R; Lehesjoki AE; Siren A; Nabbout R; Baulac S; Leguern E; Serratosa JM; Rosenow F; Feucht M; Unterberger I; Covanis A; Suls A; Weckhuysen S; Kaneva R; Caglayan H; Turkdogan D; Baykan B; Bebek N; Ozbek U; Hempelmann A; Schulz H; Rüschendorf F; Trucks H; Nürnberg P; Avanzini G; Koeleman BP; Sander T
    Epilepsia; 2012 Feb; 53(2):308-18. PubMed ID: 22242659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma.
    Janoueix-Lerosey I; Lequin D; Brugières L; Ribeiro A; de Pontual L; Combaret V; Raynal V; Puisieux A; Schleiermacher G; Pierron G; Valteau-Couanet D; Frebourg T; Michon J; Lyonnet S; Amiel J; Delattre O
    Nature; 2008 Oct; 455(7215):967-70. PubMed ID: 18923523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A human model for multigenic inheritance: phenotypic expression in Hirschsprung disease requires both the RET gene and a new 9q31 locus.
    Bolk S; Pelet A; Hofstra RM; Angrist M; Salomon R; Croaker D; Buys CH; Lyonnet S; Chakravarti A
    Proc Natl Acad Sci U S A; 2000 Jan; 97(1):268-73. PubMed ID: 10618407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.